Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod

Background. Natalizumab- (NTZ-) associated progressive multifocal leukoencephalopathy (PML) is a severe and often disabling infectious central nervous system disease that can become evident in multiple sclerosis (MS) patients after NTZ discontinuation. Recently, novel diagnostic biomarkers for the a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Case Rep Neurol Med
Päätekijät: Sinnecker, Tim, Othman, Jalal, Kühl, Marc, Metz, Imke, Niendorf, Thoralf, Kunkel, Annett, Paul, Friedemann, Wuerfel, Jens, Faiss, Juergen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2016
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138460/
https://ncbi.nlm.nih.gov/pubmed/27994897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5876798
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia